Molebogeng Ruth Lekalakala-Mokaba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Molebogeng Ruth Lekalakala-Mokaba has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Ivy Rukasha
Department of Pathology, School of Medicine, University of Limpopo, Sovenga 0727, Limpopo, South Africa
6 shared publications - Kabelo Gabriel Kaapu
Department of Pathology, School of Medicine, University of Limpopo, Sovenga 0727, Limpopo, South Africa
4 shared publications Kg Kaapu
Division of Medical Microbiology, Department of Pathology, School of Medicine, University of Limpopo, South Africa
2 shared publications- A Premjith
Mediclinic Limpopo Hospital & Day Clinic, South Africa
1 shared publication - Abhinav Sharma
Stellenbosch University
1 shared publication - Adrian John Brink
Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town , Cape Town
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1596
Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of Mycobacterium avium Complex-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing
Nontuberculous mycobacteria (NTM) pose significant diagnostic challenges in high tuberculosis (TB)-burden settings, particularly when routine molecular assays suggest multidrug-resistant TB (MDR-TB). Current diagnostic algorithms in high TB-burden settings are primarily designed to detect members of the Mycobacterium tuberculosiscomplex (MTBC) and may inadequately distinguish NTM when discordant laboratory findings are encountered. The value of this case lies not in demonstrating that whole-genome sequencing (WGS) should guide real-time treatment, but in illustrating how diagnostic uncertainty can arise when routine MTBC-focused tests fail to identify NTM and how genomic surveillance can contribute to species-level characterization in such settings. We report a complex case which was initially diagnosed as rifampicin- and isoniazid-resistant MTBC and subsequently managed according to programmatic MDR-TB guidelines. Persistent acid-fast bacilli positivity in the presence of negative MTBC antigen testing during follow-up raised suspicion of NTM involvement. Whole-genome sequencing (WGS), performed retrospectively on a follow-up isolate, identified an NTM belonging to the Mycobacterium avium complex (MAC) which was phylogenetically closest to genomes provisionally designated Mycobacterium europaeum_A and distinct from Mycobacterium europaeum sensu stricto, a member of the Mycobacterium simiae complex. The identification of a MAC-associated NTM provided an explanation for the observed diagnostic discordance but could not determine whether the organism represented colonization, sequential infection, or concurrent infection. Although WGS did not inform clinical management, it provided high-resolution species identification and highlighted important limitations of MTBC-focused diagnostic workflows when discordant microbiological findings are encountered. This case underscores the need for the targeted investigation of NTM in patients with acid-fast bacilli-positive cultures and negative MTBC antigen testing and supports the use of genomic surveillance to improve species-level identification and understanding of NTM epidemiology in high TB-burden settings such as Limpopo Province, South Africa.
- 22 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1596
Open AccessDiagnostic Discordance During MDR-TB Treatment: Retrospective Identification of Mycobacterium avium Complex-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing
Nontuberculous mycobacteria (NTM) pose significant diagnostic challenges in high tuberculosis (TB)-burden settings, particularly when routine molecular assays suggest multidrug-resistant TB (MDR-TB). Current diagnostic algorithms in high TB-burden settings are primarily designed to detect members of the Mycobacterium tuberculosiscomplex (MTBC) and may inadequately distinguish NTM when discordant laboratory findings are encountered. The value of this case lies not in demonstrating that whole-genome sequencing (WGS) should guide real-time treatment, but in illustrating how diagnostic uncertainty can arise when routine MTBC-focused tests fail to identify NTM and how genomic surveillance can contribute to species-level characterization in such settings. We report a complex case which was initially diagnosed as rifampicin- and isoniazid-resistant MTBC and subsequently managed according to programmatic MDR-TB guidelines. Persistent acid-fast bacilli positivity in the presence of negative MTBC antigen testing during follow-up raised suspicion of NTM involvement. Whole-genome sequencing (WGS), performed retrospectively on a follow-up isolate, identified an NTM belonging to the Mycobacterium avium complex (MAC) which was phylogenetically closest to genomes provisionally designated Mycobacterium europaeum_A and distinct from Mycobacterium europaeum sensu stricto, a member of the Mycobacterium simiae complex. The identification of a MAC-associated NTM provided an explanation for the observed diagnostic discordance but could not determine whether the organism represented colonization, sequential infection, or concurrent infection. Although WGS did not inform clinical management, it provided high-resolution species identification and highlighted important limitations of MTBC-focused diagnostic workflows when discordant microbiological findings are encountered. This case underscores the need for the targeted investigation of NTM in patients with acid-fast bacilli-positive cultures and negative MTBC antigen testing and supports the use of genomic surveillance to improve species-level identification and understanding of NTM epidemiology in high TB-burden settings such as Limpopo Province, South Africa.
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-13
Diagnostic Accuracy of the Biofire FilmArray Blood Culture Identification 2 (BCID2) for Bloodstream Infections in Limpopo, South Africa
Background: Bloodstream infections are a leading global cause of mortality and morbidity. Timely and accurate diagnosis improves outcomes, especially in resource-limited settings. Rapid and accurate diagnostic tools are essential for effective treatment, particularly in resource-limited settings. Our study aimed to evaluate the diagnostic performance of the BCID2 assay, comparing its effectiveness to the VITEK2 at a routine lab in Limpopo, South Africa, where alternative assays are necessary to overcome resource unavailability in areas located further away from major laboratories. Methods: This cross-sectional study was conducted from August to December 2023. A total of 247 positive blood culture bottles were tested using both BCID2 and VITEK2 systems. Statistical analysis, including specificity, sensitivity, and accuracy, was calculated using Medcalc and SPSS. Results: The BCID2 panel demonstrated a sensitivity, specificity, and accuracy of 95.7%, 95.5%, and 96%, respectively. Of the samples, 72% (179/247) were monomicrobial and 28% (68/247) were polymicrobial, with a total of 16 off-panel microorganisms identified across both groups. blaCTX-M was the most frequent Gram-negative resistance gene detected (55.2%, 80/145), while blaVIM was the least common (0.7%, 1/145). Conclusion: The study concluded that the BCID2 assay demonstrates excellent diagnostic accuracy, with sensitivity, specificity, and overall accuracy rates above 95%. Its ability to rapidly detect bloodstream infections and antimicrobial resistance markers makes it a highly effective tool, particularly in resource-limited settings like Limpopo, South Africa, where timely and accurate diagnosis is crucial to improving patient outcomes.
- 1 June 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-13
Open AccessDiagnostic Accuracy of the Biofire FilmArray Blood Culture Identification 2 (BCID2) for Bloodstream Infections in Limpopo, South Africa
Background: Bloodstream infections are a leading global cause of mortality and morbidity. Timely and accurate diagnosis improves outcomes, especially in resource-limited settings. Rapid and accurate diagnostic tools are essential for effective treatment, particularly in resource-limited settings. Our study aimed to evaluate the diagnostic performance of the BCID2 assay, comparing its effectiveness to the VITEK2 at a routine lab in Limpopo, South Africa, where alternative assays are necessary to overcome resource unavailability in areas located further away from major laboratories. Methods: This cross-sectional study was conducted from August to December 2023. A total of 247 positive blood culture bottles were tested using both BCID2 and VITEK2 systems. Statistical analysis, including specificity, sensitivity, and accuracy, was calculated using Medcalc and SPSS. Results: The BCID2 panel demonstrated a sensitivity, specificity, and accuracy of 95.7%, 95.5%, and 96%, respectively. Of the samples, 72% (179/247) were monomicrobial and 28% (68/247) were polymicrobial, with a total of 16 off-panel microorganisms identified across both groups. blaCTX-M was the most frequent Gram-negative resistance gene detected (55.2%, 80/145), while blaVIM was the least common (0.7%, 1/145). Conclusion: The study concluded that the BCID2 assay demonstrates excellent diagnostic accuracy, with sensitivity, specificity, and overall accuracy rates above 95%. Its ability to rapidly detect bloodstream infections and antimicrobial resistance markers makes it a highly effective tool, particularly in resource-limited settings like Limpopo, South Africa, where timely and accurate diagnosis is crucial to improving patient outcomes.
- Open Access
- 1 January 2026
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 8 (1) , 8
Comparative evaluation of the Xpert MTB/XDR and FluoroType XDR assays for detecting fluoroquinolone resistance in multidrug-resistant tuberculosis clinical isolates
Background: Accurate detection of fluoroquinolone (FLQ) resistance in multidrug-resistant tuberculosis (MDR-TB) is essential for effective treatment. Aim: To compare Xpert MTB/XDR and FluoroType XDR for detecting FLQ resistance in MDR-TB. Setting: National Health Laboratory Service diagnostic laboratory, Polokwane, South Africa. Methods: Seventy-eight MDR-TB isolates collected from January 2024 to July 2024 were tested using Xpert MTB/XDR, FluoroType XDR and GenoType MTBDRsl line probe assay (LPA) as the reference standard. Whole-genome sequencing (WGS) data from 35 isolates were used to resolve discordant results. Diagnostic accuracy and agreement were assessed using sensitivity, specificity and Cohen’s kappa. Results: Xpert MTB/XDR showed 97.7% sensitivity (95% confidence interval [CI]: 87.9–99.8) and 100.0% specificity (95% CI: 89.7–100.0). FluoroType XDR showed 100.0% sensitivity (95% CI: 90.6–100.0) and 97.2% specificity (95% CI: 85.5–99.9), with five indeterminate results. Compared directly with Xpert, FluoroType showed 94.9% sensitivity and 100.0% specificity. Agreement was strong (κ = 0.95; 95% CI: 0.88–1.00). WGS resolved two discordant cases: one resistant isolate with a *gyrA* Asp94Gly mutation and one susceptible isolate without resistance-associated mutations. Conclusion: Both assays performed well for FLQ resistance detection. FluoroType XDR showed higher sensitivity but more indeterminate results. Strong assay agreement and WGS resolution of discordances support their use in MDR-TB diagnostics. Contribution: This study demonstrates strong concordance between Xpert MTB/XDR and FluoroType XDR for FLQ resistance detection and highlights the value of WGS in resolving discordant results.
- 1 January 2026
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 8 (1) , 8
Open AccessComparative evaluation of the Xpert MTB/XDR and FluoroType XDR assays for detecting fluoroquinolone resistance in multidrug-resistant tuberculosis clinical isolates
Background: Accurate detection of fluoroquinolone (FLQ) resistance in multidrug-resistant tuberculosis (MDR-TB) is essential for effective treatment. Aim: To compare Xpert MTB/XDR and FluoroType XDR for detecting FLQ resistance in MDR-TB. Setting: National Health Laboratory Service diagnostic laboratory, Polokwane, South Africa. Methods: Seventy-eight MDR-TB isolates collected from January 2024 to July 2024 were tested using Xpert MTB/XDR, FluoroType XDR and GenoType MTBDRsl line probe assay (LPA) as the reference standard. Whole-genome sequencing (WGS) data from 35 isolates were used to resolve discordant results. Diagnostic accuracy and agreement were assessed using sensitivity, specificity and Cohen’s kappa. Results: Xpert MTB/XDR showed 97.7% sensitivity (95% confidence interval [CI]: 87.9–99.8) and 100.0% specificity (95% CI: 89.7–100.0). FluoroType XDR showed 100.0% sensitivity (95% CI: 90.6–100.0) and 97.2% specificity (95% CI: 85.5–99.9), with five indeterminate results. Compared directly with Xpert, FluoroType showed 94.9% sensitivity and 100.0% specificity. Agreement was strong (κ = 0.95; 95% CI: 0.88–1.00). WGS resolved two discordant cases: one resistant isolate with a *gyrA* Asp94Gly mutation and one susceptible isolate without resistance-associated mutations. Conclusion: Both assays performed well for FLQ resistance detection. FluoroType XDR showed higher sensitivity but more indeterminate results. Strong assay agreement and WGS resolution of discordances support their use in MDR-TB diagnostics. Contribution: This study demonstrates strong concordance between Xpert MTB/XDR and FluoroType XDR for FLQ resistance detection and highlights the value of WGS in resolving discordant results.
- Open Access
- 1 January 2026
- Published by AOSIS in African Journal of Primary Health Care & Family Medicine
- Vol. 19 (1) , 8-e8
Diagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting
Background: Drug-resistant tuberculosis (DR-TB) continues to be a major public health threat, especially in high-burden settings like South Africa. Rapid and accurate diagnosis of resistance to rifampicin (RIF) and isoniazid (INH) is essential to ensure that patients receive the right treatment as early as possible. Current diagnostic tools, though effective, have limitations. This study addresses the urgent need for faster, reliable alternatives to improve DR-TB detection. Aim: The aim of this study is to assess the performance of the FluoroType MTBDR assay in detecting resistance to RIF and INH in a real-world diagnostic setting. Setting: The study was carried out at the National Health Laboratory Services (NHLS) Polokwane Laboratory, a routine laboratory in Limpopo province, South Africa. Methods: We tested 152 Mycobacterium tuberculosis (MTB) isolates collected from the 2023 laboratory repository using the FluoroType MTBDR version 2 assay. These results were compared with those from two established methods: GenoType MTBDRplus and Xpert MTB/RIF Ultra. Whole genome sequencing (WGS) was used to resolve any discrepancies, serving as the reference standard. Diagnostic accuracy was evaluated using sensitivity, specificity and predictive values. Results: Of the 152 isolates, 65% were drug-resistant. FluoroType MTBDR showed excellent performance – 100% specificity and 96% sensitivity for RIF resistance and 91% sensitivity and 99% specificity for INH resistance – competing with the GenoType MTBDRplus. Conclusion: FluoroType MTBDR offers a reliable, rapid alternative for detecting DR-TB, with the potential to improve timely diagnosis and treatment. Contribution: This study highlights the FluoroType MTBDR assay as a valuable diagnostic tool for routine use, contributing to improved TB control strategies, especially in resource-limited, high-burden settings, consistent with the journal’s scope.
- 1 January 2026
- Published by AOSIS in African Journal of Primary Health Care & Family Medicine
- Vol. 19 (1) , 8-e8
Open AccessDiagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting
Background: Drug-resistant tuberculosis (DR-TB) continues to be a major public health threat, especially in high-burden settings like South Africa. Rapid and accurate diagnosis of resistance to rifampicin (RIF) and isoniazid (INH) is essential to ensure that patients receive the right treatment as early as possible. Current diagnostic tools, though effective, have limitations. This study addresses the urgent need for faster, reliable alternatives to improve DR-TB detection. Aim: The aim of this study is to assess the performance of the FluoroType MTBDR assay in detecting resistance to RIF and INH in a real-world diagnostic setting. Setting: The study was carried out at the National Health Laboratory Services (NHLS) Polokwane Laboratory, a routine laboratory in Limpopo province, South Africa. Methods: We tested 152 Mycobacterium tuberculosis (MTB) isolates collected from the 2023 laboratory repository using the FluoroType MTBDR version 2 assay. These results were compared with those from two established methods: GenoType MTBDRplus and Xpert MTB/RIF Ultra. Whole genome sequencing (WGS) was used to resolve any discrepancies, serving as the reference standard. Diagnostic accuracy was evaluated using sensitivity, specificity and predictive values. Results: Of the 152 isolates, 65% were drug-resistant. FluoroType MTBDR showed excellent performance – 100% specificity and 96% sensitivity for RIF resistance and 91% sensitivity and 99% specificity for INH resistance – competing with the GenoType MTBDRplus. Conclusion: FluoroType MTBDR offers a reliable, rapid alternative for detecting DR-TB, with the potential to improve timely diagnosis and treatment. Contribution: This study highlights the FluoroType MTBDR assay as a valuable diagnostic tool for routine use, contributing to improved TB control strategies, especially in resource-limited, high-burden settings, consistent with the journal’s scope.
- Open Access
- 1 June 2025
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 7 (1) , 16-21
Prevalence of gene mutations associated with isoniazid resistance in drug-resistant tuberculosis: a study from Limpopo, South Africa
- 1 June 2025
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 7 (1) , 16-21
Open AccessPrevalence of gene mutations associated with isoniazid resistance in drug-resistant tuberculosis: a study from Limpopo, South Africa
- Open Access
- 18 March 2024
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 114 (3) , e702
Determination of anti-COVID-19 IgG and IgM seroprevalence among pregnant women at Pietersburg Hospital, Limpopo Province, South Africa
Background. COVID-19 has been a major public health concern globally, leading to a higher mortality rate, especially among immunosuppressed individuals, who include pregnant women, people with HIV and people living with other comorbidities. Pregnant women are considered to be a special population group owing to their specific susceptibility to some infectious diseases. Objective. To determine the seroprevalence of anti-SARS-CoV-2 antibodies among pregnant women attending an antenatal clinic. Method. This was a descriptive cross-sectional study that tested blood samples from pregnant women who attended the antenatal clinic from March to July 2022 using the Orient Gene Biotech lateral flow immune-chromatographic assay according to manufacturer instructions. The assay detects IgM and IgG antibodies against SARS-CoV-2. Results. A total of 2 649 blood samples were tested; 2 039 (77.0%) samples tested positive for IgG, 7 (0.3%) tested positive for IgM, and 100 (3.7%) tested positive for both IgG and IgM. The study found a seroprevalence of 80.7% of IgG. Conclusion. The study findings showed evidence of acute COVID-19 infection in our patient population despite the consensus that COVID-19 infection is dissipating.
- 18 March 2024
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 114 (3) , e702
Open AccessDetermination of anti-COVID-19 IgG and IgM seroprevalence among pregnant women at Pietersburg Hospital, Limpopo Province, South Africa
Background. COVID-19 has been a major public health concern globally, leading to a higher mortality rate, especially among immunosuppressed individuals, who include pregnant women, people with HIV and people living with other comorbidities. Pregnant women are considered to be a special population group owing to their specific susceptibility to some infectious diseases. Objective. To determine the seroprevalence of anti-SARS-CoV-2 antibodies among pregnant women attending an antenatal clinic. Method. This was a descriptive cross-sectional study that tested blood samples from pregnant women who attended the antenatal clinic from March to July 2022 using the Orient Gene Biotech lateral flow immune-chromatographic assay according to manufacturer instructions. The assay detects IgM and IgG antibodies against SARS-CoV-2. Results. A total of 2 649 blood samples were tested; 2 039 (77.0%) samples tested positive for IgG, 7 (0.3%) tested positive for IgM, and 100 (3.7%) tested positive for both IgG and IgM. The study found a seroprevalence of 80.7% of IgG. Conclusion. The study findings showed evidence of acute COVID-19 infection in our patient population despite the consensus that COVID-19 infection is dissipating.
- Open Access
- 22 December 2023
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 13 (1) , 8
ESKAPE pathogen incidence and antibiotic resistance in patients with bloodstream infections at a referral hospital in Limpopo, South Africa, 2014–2019: A cross-sectional study
Background: There is a paucity of research on the incidence and antimicrobial resistance (AMR) of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE) pathogens in Africa because of the inadequate establishment of AMR surveillance systems. Objective: This study reports on the incidence and AMR of bloodstream ESKAPE pathogens at a referral hospital in northern South Africa. Methods: This retrospective descriptive study used routinely collected bloodstream isolates (pathogen identification and antimicrobial susceptibility testing performed using automated systems) from the South African National Health Laboratory Service, from January 2014 to December 2019. Resistant phenotypes analysed included methicillin-resistant S. aureus and carbapenem-resistant A. baumannii. Results: The ESKAPE pathogen incidence rate was stable from 2014 to 2019 (p = 0.133). The most isolated pathogens were S. aureus (268/746; 35.9%) and A. baumannii (200/746; 26.8%). Staphylococcus aureus increased from 39 isolates in 2014 to 75 in 2019 (p = 0.132). The incidence rate of A. baumannii increased from 11.9% (16/134) in 2015 to 37.8% (68/180) in 2019 (p = 0.009). Most isolates (417/746; 55.9%) were from the neonatal ward. Carbapenem-resistant A. baumannii increased from 68.8% (11/16) in 2014 to 75.0% (51/68) in 2019 (p = 0.009). Methicillin-resistant S. aureus decreased from 56.0% (14/25) in 2016 to 17.3% (13/75) in 2019 (p = 0.260). Conclusion: Routine data provide essential information on the incidence of ESKAPE pathogens and AMR phenotypes, serving as a basis for an antibiogram, a surveillance tool in antibiotic stewardship programmes. What this study adds: The study provided local information on the incidence and AMR pattern of ESKAPE pathogens, which is essential when developing empiric treatment protocols for appropriate antibiotic prescribing and infection prevention and control practices.
- 22 December 2023
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 13 (1) , 8
Open AccessESKAPE pathogen incidence and antibiotic resistance in patients with bloodstream infections at a referral hospital in Limpopo, South Africa, 2014–2019: A cross-sectional study
Background: There is a paucity of research on the incidence and antimicrobial resistance (AMR) of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE) pathogens in Africa because of the inadequate establishment of AMR surveillance systems. Objective: This study reports on the incidence and AMR of bloodstream ESKAPE pathogens at a referral hospital in northern South Africa. Methods: This retrospective descriptive study used routinely collected bloodstream isolates (pathogen identification and antimicrobial susceptibility testing performed using automated systems) from the South African National Health Laboratory Service, from January 2014 to December 2019. Resistant phenotypes analysed included methicillin-resistant S. aureus and carbapenem-resistant A. baumannii. Results: The ESKAPE pathogen incidence rate was stable from 2014 to 2019 (p = 0.133). The most isolated pathogens were S. aureus (268/746; 35.9%) and A. baumannii (200/746; 26.8%). Staphylococcus aureus increased from 39 isolates in 2014 to 75 in 2019 (p = 0.132). The incidence rate of A. baumannii increased from 11.9% (16/134) in 2015 to 37.8% (68/180) in 2019 (p = 0.009). Most isolates (417/746; 55.9%) were from the neonatal ward. Carbapenem-resistant A. baumannii increased from 68.8% (11/16) in 2014 to 75.0% (51/68) in 2019 (p = 0.009). Methicillin-resistant S. aureus decreased from 56.0% (14/25) in 2016 to 17.3% (13/75) in 2019 (p = 0.260). Conclusion: Routine data provide essential information on the incidence of ESKAPE pathogens and AMR phenotypes, serving as a basis for an antibiogram, a surveillance tool in antibiotic stewardship programmes. What this study adds: The study provided local information on the incidence and AMR pattern of ESKAPE pathogens, which is essential when developing empiric treatment protocols for appropriate antibiotic prescribing and infection prevention and control practices.
- Open Access
- 1 December 2023
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 5 (2) , 88-94
Gram-positive pathogens in skin and soft tissue infections: is resistance a challenge in clinical practice?
- 1 December 2023
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 5 (2) , 88-94
Open AccessGram-positive pathogens in skin and soft tissue infections: is resistance a challenge in clinical practice?
- Open Access
- 1 June 2022
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 4 (2) , 108-110
A laboratory case of Emergomyces africanus
Emergomyces africanus (Es. africanus) is a novel thermally-dimorphic fungal pathogen, which belongs to the Ajellomycetaceae family. Several species have been described within the Emergomyces genus, namely Es. africanus, Es. canadensis, Es. pasteurianus, ...
- 1 June 2022
- Published by AOSIS in The Journal of Medical Laboratory Science and Technology of South Africa
- Vol. 4 (2) , 108-110
Open AccessA laboratory case of Emergomyces africanus
Emergomyces africanus (Es. africanus) is a novel thermally-dimorphic fungal pathogen, which belongs to the Ajellomycetaceae family. Several species have been described within the Emergomyces genus, namely Es. africanus, Es. canadensis, Es. pasteurianus, ...
- Open Access
- 16 November 2020
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 35 (1) , 7
Epidemiological investigation of a typhoid fever outbreak in Sekhukhune District, Limpopo province, South Africa – 2017
Background: Typhoid fever remains a public health concern in South Africa, where the risk of transmission is high because of poor access to safe water and sanitation. This study describes the investigation of typhoid fever outbreak in Limpopo province. Methodology: Following notification of laboratory-confirmed cases, a descriptive study was conducted at Sekhukhune District, Limpopo province. A suspected case was defined as any person residing in Makhuduthamaga Municipality from November 2017 to January 2018, presenting with fever and gastrointestinal symptoms. Data were collected using case investigation forms. Whole-genome sequencing (WGS) was carried out on Salmonella Typhi isolates and polymerase chain reaction (PCR) test was done for Salmonella species from water samples. Location of cases and water sources were mapped using ArcGIS mapping tool. Results: Amongst 122 cases, 54% (n = 66) were female and 6% (n = 7) laboratory-confirmed. The median age of the cases was 11 years (range 2–83 years), with 79% (n = 102) being children under the age of 14 years. Salmonella species were detected in 37% (10/27) of water samples and geographic information system (GIS) mapping showed clustering of cases in Tswaing-Kgwaripe and Vlakplaas villages. Six isolates were available for WGS analysis, with resulting data showing that five of the six isolates were genetically related. Phylogenetic analysis showed that the five isolates clustered together were genetically related showing < 22 single nucleotide polymorphisms when compared to each other. Conclusion: Molecular epidemiology of isolates suggests a common source outbreak, supported by the detection of Salmonella species from water sources. Consumption of water from contaminated open water sources, because of ongoing interruption of municipal water supply, was the likely cause of the outbreak. The investigation highlights the importance of consistent safe water supply and the ability of district surveillance systems to identify and contain outbreaks.
- 16 November 2020
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 35 (1) , 7
Open AccessEpidemiological investigation of a typhoid fever outbreak in Sekhukhune District, Limpopo province, South Africa – 2017
Background: Typhoid fever remains a public health concern in South Africa, where the risk of transmission is high because of poor access to safe water and sanitation. This study describes the investigation of typhoid fever outbreak in Limpopo province. Methodology: Following notification of laboratory-confirmed cases, a descriptive study was conducted at Sekhukhune District, Limpopo province. A suspected case was defined as any person residing in Makhuduthamaga Municipality from November 2017 to January 2018, presenting with fever and gastrointestinal symptoms. Data were collected using case investigation forms. Whole-genome sequencing (WGS) was carried out on Salmonella Typhi isolates and polymerase chain reaction (PCR) test was done for Salmonella species from water samples. Location of cases and water sources were mapped using ArcGIS mapping tool. Results: Amongst 122 cases, 54% (n = 66) were female and 6% (n = 7) laboratory-confirmed. The median age of the cases was 11 years (range 2–83 years), with 79% (n = 102) being children under the age of 14 years. Salmonella species were detected in 37% (10/27) of water samples and geographic information system (GIS) mapping showed clustering of cases in Tswaing-Kgwaripe and Vlakplaas villages. Six isolates were available for WGS analysis, with resulting data showing that five of the six isolates were genetically related. Phylogenetic analysis showed that the five isolates clustered together were genetically related showing < 22 single nucleotide polymorphisms when compared to each other. Conclusion: Molecular epidemiology of isolates suggests a common source outbreak, supported by the detection of Salmonella species from water sources. Consumption of water from contaminated open water sources, because of ongoing interruption of municipal water supply, was the likely cause of the outbreak. The investigation highlights the importance of consistent safe water supply and the ability of district surveillance systems to identify and contain outbreaks.